Multidisciplinary efforts help promote the success of clinical trials and innovation for patients with various forms of ...

Dr. Kara Kelly discusses the unique challenges that adolescent and young adult patients with cancer face following their ...

New research disentangles the risks for acute kidney injury related to CAR T-cell treatment in non-Hodgkin lymphoma, ...

The Phase I trial involved 10 patients with relapsed or refractory classical Hodgkin lymphoma or CD30 + T-cell lymphoma, yielding highly positive results. Dr. Javier Briones, Head of the ...

The phase I clinical trial included ten patients with relapsed or refractory classical Hodgkin lymphoma or CD30-positive T-cell lymphoma, with very positive results. According to Dr. Javier Briones, ...

To diagnose non-Hodgkin‘s lymphoma, doctors may use blood tests, biopsies, and imaging scans such as CT scans or MRIs. These tests help doctors confirm the presence of the disease and plan the ...

Promising results in the Phase I clinical trial The Phase I clinical trial involved ten patients with relapsed or refractory classical Hodgkin lymphoma or CD30+ T-cell lymphoma, yielding highly ...